Otto M van Delden (Otto M Van Delden)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Topics

Liver Metastases

Renal Cell Carcinoma

Top Venues

European journal of nuclear medicine and molecular imaging

Liver international : official journal of the International Association for the Study of the Liver

JMIR research protocols

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel, Minneke J Coenraad, Mark J Arntz, Roel J Bennink, Andries E Braat, Stijn Crobach, Otto M van Delden, Petra Dibbets-Schneider, Tom van der Hulle, Heinz-Josef Klümpen, Rutger W van der Meer, Johannes Frank Wilhelmus Nijsen, Catharina S P van Rijswijk, Joey Roosen, Bastian N Ruijter, Frits Smit, Mette K Stam, R Bart Takkenberg, Maarten E Tushuizen, Floris H P van Velden, Lioe-Fee De Geus-Oei, Mark C Burgmans, null null
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial). European journal of nuclear medicine and molecular imaging 51 (7) (2024)
Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel, Minneke J Coenraad, Mark J Arntz, Roel J Bennink, Andries E Braat, Stijn Crobach, Otto M van Delden, Petra Dibbets-Schneider, Tom van der Hulle, Heinz-Josef Klümpen, Rutger W van der Meer, Johannes Frank Wilhelmus Nijsen, Catharina S P van Rijswijk, Joey Roosen, Bastian N Ruijter, Frits Smit, Mette K Stam, R Bart Takkenberg, Maarten E Tushuizen, Floris H P van Velden, Lioe-Fee De Geus-Oei, Mark C Burgmans, null null
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial). European journal of nuclear medicine and molecular imaging (2024)
Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel, Minneke J Coenraad, Mark J Arntz, Roel J Bennink, Andries E Braat, Stijn Crobach, Otto M van Delden, Petra Dibbets-Schneider, Tom van der Hulle, Heinz-Josef Klümpen, Rutger W van der Meer, Johannes Frank Wilhelmus Nijsen, Catharina S P van Rijswijk, Joey Roosen, Bastian N Ruijter, Frits Smit, Mette K Stam, R Bart Takkenberg, Maarten E Tushuizen, Floris H P van Velden, Lioe-Fee De Geus-Oei, Mark C Burgmans, null null
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial). European journal of nuclear medicine and molecular imaging 51 (7) (2024)
Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel, Minneke J Coenraad, Mark J Arntz, Roel J Bennink, Andries E Braat, Stijn Crobach, Otto M van Delden, Petra Dibbets-Schneider, Tom van der Hulle, Heinz-Josef Klümpen, Rutger W van der Meer, Johannes Frank Wilhelmus Nijsen, Catharina S P van Rijswijk, Joey Roosen, Bastian N Ruijter, Frits Smit, Mette K Stam, R Bart Takkenberg, Maarten E Tushuizen, Floris H P van Velden, Lioe-Fee De Geus-Oei, Mark C Burgmans, null null
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial). European journal of nuclear medicine and molecular imaging 51 (7) (2024)
Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel, Minneke J Coenraad, Mark J Arntz, Roel J Bennink, Andries E Braat, Stijn Crobach, Otto M van Delden, Petra Dibbets-Schneider, Tom van der Hulle, Heinz-Josef Klümpen, Rutger W van der Meer, Johannes Frank Wilhelmus Nijsen, Catharina S P van Rijswijk, Joey Roosen, Bastian N Ruijter, Frits Smit, Mette K Stam, R Bart Takkenberg, Maarten E Tushuizen, Floris H P van Velden, Lioe-Fee De Geus-Oei, Mark C Burgmans, null null
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial). European journal of nuclear medicine and molecular imaging 51 (7) (2024)
Tim A Labeur, Sarah Berhane, Julien Edeline, Jean-Frederic Blanc, Dominic Bettinger, Tim Meyer, Jeroen L A Van Vugt, David W G Ten Cate, Robert A De Man, Ferry A L M Eskens, Alessandro Cucchetti, Laura Jayne Bonnett, Otto M van Delden, Heinz-Josef Klümpen, R Bart Takkenberg, Philip J Johnson
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib. Liver international : official journal of the International Association for the Study of the Liver 40 (1) (2019)
Rosalie C Oey, Koos de Wit, Adriaan Moelker, Tugce Atalik, Otto M van Delden, Geert Maleux, Nicole Stephanie Erler, R Bart Takkenberg, Robert A de Man, Frederik Nevens, Henk R van Buuren
Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study. Alimentary pharmacology & therapeutics 48 (9) (2018)
Tim A Labeur, David W G Ten Cate, R Bart Takkenberg, Hicham Azahaf, Martijn G H van Oijen, Otto M van Delden, Robert A de Man, Jeroen L A van Vugt, Jan Nicolaas Maria IJzermans, Ferry A L M Eskens, Heinz-Josef Klümpen
Are we SHARP enough? The importance of adequate patient selection in sorafenib treatment for hepatocellular carcinoma. Acta oncologica (Stockholm, Sweden) 57 (11) (2018)
Mara Buijs, Krijn P van Lienden, Peter Gk Wagstaff, Matthijs J V Scheltema, Daniel Martijn de Bruin, Patricia J Zondervan, Otto M van Delden, Ton G van Leeuwen, Jean J M C H de la Rosette, Maria Pilar Laguna Pes
Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b). JMIR research protocols 6 (2) (2017)